Translational Health Science and Technology Institute (THSTI), India and the International AIDS Vaccine Initiative (IAVI), USA have set up a collaborative program entitled“ HIV Vaccine Translational Research” (HVTR) to accelerate and advance HIV vaccine research and development. The program is an integral part of the THSTI cluster of research centers and linked to global network of R& D facilities, including IAVIs Neutralizing Antibody Consortium (NAC) and IAVI Design and Development lab, situated in Brooklyn, New York. The THSTI - IAVI HIV Vaccine Design Lab examines novel AIDS vaccine platforms and immunogens, standardizes preclinical testing of AIDS vaccine candidates, and develops candidates for evaluation in clinical trials. It is an innovative discovery program directed at designing, testing and implementing high - throughput (HT) strategies for HIV - 1 envelope - based immunogen screening and prioritization to help discover and advance novel HIV vaccine candidates. The program is targeted to expand the number of vaccine candidates for testing, and enhance the speed with which they can be assayed. The unique industrial - type high - throughput vaccine design, screening and selection processes proposed will be largely facilitated by interdisciplinary interaction and thus driven by principles of international collaboration, high - quality science and vaccine - oriented applied research.
To strengthen its research mission, “HIV Vaccine Translational Research” (HVTR) is seeking to fill the positions of Scientist and Senior Scientist. The details of these positions are provided below.